Effect of risedronate on speed of sound in postmenopausal women with osteoporosis

Jun Iwamoto, Tetsuya Takada, Yoshihiro Sato, Hideo Matsumoto

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Aim: To examine the effects of treatment with risedronate for 1 year on speed of sound (SOS) of the calcaneus and bone turnover markers in postmenopausal women with osteoporosis. Methods: Thirty-eight postmenopausal women with osteoporosis who had been treated with risedronate for > 1 year were enrolled in the study. The SOS and bone turnover markers were monitored during treatment with risedronate for 1 year. Results: The urinary levels of cross-linked N-terminal telopeptides of type I collagen and serum levels of alkaline phosphatase were significantly decreased at 3 mo (-34.7%) and 12 mo (-21.2%), respectively, compared with the baseline values. The SOS increased modestly, but significantly by 0.65% at 12 mo compared with the baseline value. Treatment with risedronate elicited an increase in the SOS of the calcaneus exceeding the coefficient of variation in vivo (0.27%). Conclusion: The present study confirmed that risedronate suppressed bone turnover and elicited a clinically significant increase in the SOS of the calcaneus in postmenopausal women with osteoporosis.

Original languageEnglish
Pages (from-to)316-322
Number of pages7
JournalWorld Journal of Orthopaedics
Volume4
Issue number4
DOIs
Publication statusPublished - 2013 Oct 18

Fingerprint

Osteoporosis
Calcaneus
Bone Remodeling
Alkaline Phosphatase
Therapeutics
Risedronate Sodium
Serum

Keywords

  • Bone turnover
  • Postmenopausal women
  • Quantitative ultrasound
  • Risedronate
  • Speed of sound

ASJC Scopus subject areas

  • Orthopedics and Sports Medicine

Cite this

Effect of risedronate on speed of sound in postmenopausal women with osteoporosis. / Iwamoto, Jun; Takada, Tetsuya; Sato, Yoshihiro; Matsumoto, Hideo.

In: World Journal of Orthopaedics, Vol. 4, No. 4, 18.10.2013, p. 316-322.

Research output: Contribution to journalArticle

Iwamoto, Jun ; Takada, Tetsuya ; Sato, Yoshihiro ; Matsumoto, Hideo. / Effect of risedronate on speed of sound in postmenopausal women with osteoporosis. In: World Journal of Orthopaedics. 2013 ; Vol. 4, No. 4. pp. 316-322.
@article{a34ef51bb3ca46a388237b4228777886,
title = "Effect of risedronate on speed of sound in postmenopausal women with osteoporosis",
abstract = "Aim: To examine the effects of treatment with risedronate for 1 year on speed of sound (SOS) of the calcaneus and bone turnover markers in postmenopausal women with osteoporosis. Methods: Thirty-eight postmenopausal women with osteoporosis who had been treated with risedronate for > 1 year were enrolled in the study. The SOS and bone turnover markers were monitored during treatment with risedronate for 1 year. Results: The urinary levels of cross-linked N-terminal telopeptides of type I collagen and serum levels of alkaline phosphatase were significantly decreased at 3 mo (-34.7{\%}) and 12 mo (-21.2{\%}), respectively, compared with the baseline values. The SOS increased modestly, but significantly by 0.65{\%} at 12 mo compared with the baseline value. Treatment with risedronate elicited an increase in the SOS of the calcaneus exceeding the coefficient of variation in vivo (0.27{\%}). Conclusion: The present study confirmed that risedronate suppressed bone turnover and elicited a clinically significant increase in the SOS of the calcaneus in postmenopausal women with osteoporosis.",
keywords = "Bone turnover, Postmenopausal women, Quantitative ultrasound, Risedronate, Speed of sound",
author = "Jun Iwamoto and Tetsuya Takada and Yoshihiro Sato and Hideo Matsumoto",
year = "2013",
month = "10",
day = "18",
doi = "10.5312/wjo.v4.i4.316",
language = "English",
volume = "4",
pages = "316--322",
journal = "World Journal of Orthopaedics",
issn = "2218-5836",
publisher = "di xue qian yuan bian ji bu",
number = "4",

}

TY - JOUR

T1 - Effect of risedronate on speed of sound in postmenopausal women with osteoporosis

AU - Iwamoto, Jun

AU - Takada, Tetsuya

AU - Sato, Yoshihiro

AU - Matsumoto, Hideo

PY - 2013/10/18

Y1 - 2013/10/18

N2 - Aim: To examine the effects of treatment with risedronate for 1 year on speed of sound (SOS) of the calcaneus and bone turnover markers in postmenopausal women with osteoporosis. Methods: Thirty-eight postmenopausal women with osteoporosis who had been treated with risedronate for > 1 year were enrolled in the study. The SOS and bone turnover markers were monitored during treatment with risedronate for 1 year. Results: The urinary levels of cross-linked N-terminal telopeptides of type I collagen and serum levels of alkaline phosphatase were significantly decreased at 3 mo (-34.7%) and 12 mo (-21.2%), respectively, compared with the baseline values. The SOS increased modestly, but significantly by 0.65% at 12 mo compared with the baseline value. Treatment with risedronate elicited an increase in the SOS of the calcaneus exceeding the coefficient of variation in vivo (0.27%). Conclusion: The present study confirmed that risedronate suppressed bone turnover and elicited a clinically significant increase in the SOS of the calcaneus in postmenopausal women with osteoporosis.

AB - Aim: To examine the effects of treatment with risedronate for 1 year on speed of sound (SOS) of the calcaneus and bone turnover markers in postmenopausal women with osteoporosis. Methods: Thirty-eight postmenopausal women with osteoporosis who had been treated with risedronate for > 1 year were enrolled in the study. The SOS and bone turnover markers were monitored during treatment with risedronate for 1 year. Results: The urinary levels of cross-linked N-terminal telopeptides of type I collagen and serum levels of alkaline phosphatase were significantly decreased at 3 mo (-34.7%) and 12 mo (-21.2%), respectively, compared with the baseline values. The SOS increased modestly, but significantly by 0.65% at 12 mo compared with the baseline value. Treatment with risedronate elicited an increase in the SOS of the calcaneus exceeding the coefficient of variation in vivo (0.27%). Conclusion: The present study confirmed that risedronate suppressed bone turnover and elicited a clinically significant increase in the SOS of the calcaneus in postmenopausal women with osteoporosis.

KW - Bone turnover

KW - Postmenopausal women

KW - Quantitative ultrasound

KW - Risedronate

KW - Speed of sound

UR - http://www.scopus.com/inward/record.url?scp=84892975471&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84892975471&partnerID=8YFLogxK

U2 - 10.5312/wjo.v4.i4.316

DO - 10.5312/wjo.v4.i4.316

M3 - Article

AN - SCOPUS:84892975471

VL - 4

SP - 316

EP - 322

JO - World Journal of Orthopaedics

JF - World Journal of Orthopaedics

SN - 2218-5836

IS - 4

ER -